Advertisement

Topics

Sponsors and CROs Rely on Analytics in Clinical Research but Are Limited to Traditional and In-House Data, Medidata Finds

08:30 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Survey Results Reveal Top Challenges Facing Life Sciences Companies Today, as Well as Emerging Data Sets, Technologies and Trends to Alleviate Hurdles in Drug Development Medidata (NASDAQ:MDSO), the leading global pro...

Other Sources for this Article

Medidata Solutions
Investor:
Anthony D’Amico, +1 732-767-4331
adamico@mdsol.com
or
Media:
Erik Snider, +1 646-362-2997
esnider@mdsol.com

NEXT ARTICLE

More From BioPortfolio on "Sponsors and CROs Rely on Analytics in Clinical Research but Are Limited to Traditional and In-House Data, Medidata Finds"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...